The invention provides corticotrophin releasing factor (CRF) antagonists, the formulas of which are (I) or (II):<IMAGE>They are intended to be used for treating anxiety, depression and other psychic and neurological disorders.
申请公布号
LT4533(B)
申请公布日期
1999.08.25
申请号
LT19980000133
申请日期
1998.09.21
申请人
DU PONT PHARMACEUTICALS COMPANY
发明人
BAKTHAVATCHALAM,RAJAGOPAL;ARVANITIS,ARGYRIOS GEORGIOS;BECK,JAMES PETER;CAIN,GARY AVONN;CHORVAT,ROBERT JOHN;GILLIGAN,PAUL JOSEPH;OLSON,RICHARD ERIC
